Immucell (ICCC) Gross Profit Growth (1y) (2011 - 2026)
Powered by 
Analysis
Immucell (ICCC) Gross Profit Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 12.14% |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | -8.36% |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | 11.92% |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | 22.17% |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | -13.51% |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -13.51% |
| Dec 31, 2025 | 2.77% |
| Sep 30, 2025 | 49.23% |
| Jun 30, 2025 | 129.01% |
| Mar 31, 2025 | 46.12% |
| Sep 30, 2024 | 25.00% |
| Jun 30, 2024 | 17.88% |
| Mar 31, 2024 | 663.15% |
| Sep 30, 2023 | -31.37% |
| Jun 30, 2023 | -38.86% |
| Mar 31, 2023 | -90.31% |
| Dec 31, 2022 | -61.25% |
| Sep 30, 2022 | -23.68% |
| Jun 30, 2022 | -17.69% |
| Mar 31, 2022 | 93.69% |
| Dec 31, 2021 | 57.97% |
| Sep 30, 2021 | 40.42% |
| Jun 30, 2021 | 61.65% |
| Mar 31, 2021 | -28.35% |
| Dec 31, 2020 | -11.81% |